Cancers,
Journal Year:
2024,
Volume and Issue:
16(20), P. 3546 - 3546
Published: Oct. 21, 2024
:
In
recent
decades,
a
significant
global
increase
in
the
incidence
of
non-melanoma
skin
cancer
has
been
observed.
To
explore
pathogenesis
and
potential
therapeutic
approaches
for
squamous
cell
carcinoma,
various
vivo
studies
using
mouse
models
have
conducted.
However,
investigations
comparing
different
hairless
models,
with
or
without
melanin,
as
well
hypercholesterolemia
immunosuppression,
terms
their
ability
to
induce
carcinoma
yet
be
undertaken.
Science Advances,
Journal Year:
2024,
Volume and Issue:
10(42)
Published: Oct. 16, 2024
A
major
therapeutic
barrier
in
melanoma
is
the
coexistence
of
diverse
cellular
states
marked
by
distinct
metabolic
traits.
Transitioning
from
a
proliferative
to
an
invasive
phenotype
coupled
with
increased
ferroptosis
vulnerability.
However,
regulatory
circuits
controlling
susceptibility
across
cell
are
unknown.
In
this
work,
we
identified
Apolipoprotein
E
(
APOE
)
as
top
lipid-metabolism
gene
segregating
MITF
high
/AXL
low
proliferative/ferroptosis-resistant
invasive/ferroptosis-sensitive
state.
Mechanistically,
ApoE
secreted
cells
protects
ferroptosis-inducing
agents
reducing
content
peroxidation-prone
polyunsaturated
fatty
acids
and
boosting
GPX4
levels
both
vitro
vivo.
Whole-exome
sequencing
indicates
that
expression
patients
associated
resistance
ferroptosis,
regardless
germline
status.
aggregate,
found
ferroptosis-resistance
mechanism
between
relying
on
potential
biomarker
for
poor
response
melanoma.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1016 - 1016
Published: Jan. 25, 2025
Colorectal
cancer
(CRC)
and
lung
(LC)
are
leading
causes
of
cancer-related
mortality,
highlighting
the
need
for
minimally
invasive
diagnostic,
prognostic,
predictive
markers
these
cancers.
Proteins
secreted
by
a
tumor
into
extracellular
space
directly,
known
as
secretome,
well
proteins
in
extra-cellular
vesicles
(EVs),
represent
an
attractive
source
biomarkers
CRC
LC.
We
performed
proteomic
analyses
on
secretome
EV
samples
from
LC
(A549,
NCI-H23,
NCI-H460)
(Caco2,
HCT116,
HT-29)
cell
lines
targeted
mass
spectrometry
EVs
plasma
20
patients
with
19
healthy
controls.
A
total
782
were
identified
across
samples.
Of
these,
22
44
protein
significantly
elevated
samples,
respectively.
Functional
annotation
revealed
enrichment
linked
to
metastasis
progression
both
types.
In
isolated
CRC,
ITGB3,
HSPA8,
TUBA4A,
TLN1
reduced,
whereas
FN1,
SERPINA1,
CST3
elevated,
compared
These
findings
support
development
liquid
biopsy
methods
detection,
prognosis,
treatment
monitoring
CRC.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(3), P. 196 - 196
Published: March 12, 2025
Background:
Psoriasis
is
a
chronic,
multi-system
inflammatory
disease
frequently
associated
with
metabolic
syndrome
and
lipid
disturbances.
Apolipoproteins,
as
essential
regulators
of
metabolism,
may
play
critical
role
in
these
abnormalities,
potentially
influencing
severity
systemic
inflammation.
The
aim
this
study
was
to
compare
serum
concentrations
chosen
apolipoproteins
patients
psoriasis
before
after
treatment
acitretin
or
narrowband
UVB
(NB-UVB).
Methods:
This
conducted
on
39
psoriasis.
concentration
nine
C-reactive
protein
quantified
using
the
Bio-Plex
Immunoassay
Kit.
Results:
ApoA2,
ApoC1,
ApoD,
ApoE,
ApoJ
were
higher
group
compared
NB-UVB
treatment,
while
ApoA1/ApoA2
ratio
lower.
We
also
observed
negative
association
between
Area
Severity
Index
(PASI)
treatment.
Conclusions:
results
confirm
presence
disturbances
psoriatic
patients.
did
not
cause
any
significant
changes
profile.
Thus,
we
found
no
detrimental
impact
profile,
despite
rise
total
cholesterol
Further
research
needed
explore
whether
specific
therapeutic
approaches
can
modify
improve
long-term
cardiovascular
outcomes
population.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 31, 2025
Background
Studies
have
shown
that
ESCRT
genes
affect
cell
aging,
immune
environment,
and
tumors.
BRCA
was
used
to
explore
its
effects
on
tumor
prognosis
therapy.
Methods
The
data
sets
of
Cancer
Genome
Atlas
(TCGA),
Genome-Tissue
Expression
Plan
(GTEX),
Human
Protein
Mapping
(HPA),
Gene
Omnibus
(GEO),
Clinical
Proteomic
Tumor
Analysis
Consortium
(CPTAC),
R
software
package,
bioinformatics
methods
were
mine
the
potential
carcinogenic
ESCRT,
including
expression
level,
prognostic
value,
value
in
various
types
tissues,
function
family
further
verified
breast
cancer.
Results
showed
significant
differential
cancers,
such
as
bladder
urothelial
carcinoma
liver,
cervical,
renal,
esophageal,
head,
neck
cancers
(
P
<
0.05).
Abnormal
is
associated
with
poor
adrenocortical
carcinoma,
cancer,
cervical
cancer
level
significantly
infiltration
modulation
stromal/immune
score
(all
Enrichment
analysis
immune-related
functions
transport
signaling
pathways
cells.
Moreover,
serves
an
early
diagnostic
marker
for
several
tumors
prognosis.
This
confirms
most
immune-infiltrating
cells
pan-carcinomas.
Taken
together,
these
studies
highlight
importance
gene
VPS37D
initiation,
progression,
response.
Conclusion
study
highlights
ESCRT’s
detection
via
pan-cancer
analysis,
showing
variations
between
normal
role
progression
through
microenvironment,
specificity
sensitivity
detection.
gene,
variation
predicts
patient
related
suggesting
a
novel
biomarker
diagnosis
assessment.
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 21
Published: April 15, 2025
Metabolic
reprogramming
is
one
of
the
hallmarks
breast
cancer
(BC),
involving
elevated
synthesis
and
uptake
lipids,
for
catering
to
increased
energy
demand
cells
suppress
host
immune
system.
Besides
promoting
proliferation
survival
BC
cells,
lipid
metabolism
(LMR)
associated
with
stemness
chemoresistance.
Recently,
lignans
have
been
reported
their
therapeutic
potential
against
different
cancers,
including
BC.
Here,
we
explored
target
LMR
pathways
in
through
computational
approach.
Initially,
88
having
anticancer
activities,
underwent
druglikeness
pharmacokinetics
analysis,
displaying
promising
pharmacokinetic
properties,
except
13
molecules
violations.
Molecular
docking
assessed
interaction
(NPACT)
targets
3-Hydroxy-3-methyl-glutaryl-coenzyme
A
reductase
(HMGCR),
Sterol
regulatory
element-binding
proteins
1
2
(SREBP1
2),
Low-density
lipoprotein
receptor
(LDLR),
Acetyl-CoA
Acetyltransferase
(ACAT1),
ATP-binding
cassette
transporter
(ABCA1),
Liver
X
α
(LXRα),
Apolipoprotein
A1
(APOA1),
Fatty
Acid
Synthase
(FASN),
Peroxisome
proliferator-activated
gamma
(PPARG),
Stearoyl-CoA
desaturase
(SCD1),
carboxylase
(ACC1/ACACA,
ACC2/ACACB).
In
silico
screening
revealed
sesamin
(SE)
as
best-identified
hit
that
showed
stable
consistent
binding
all
selected
LMR.
The
stability
these
complexes
was
validated
by
a
100
ns
simulation
run,
free
calculation
determined
MM-PBSA
method.
Interestingly,
SE
modulated
mRNA
expression
genes
involved
cell
lines,
MCF-7
MDA-MB-231,
thereby
suggesting
its
an
inhibitor
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: May 11, 2025
The
apolipoprotein
C
(Apoc)
family
comprises
a
group
of
low-molecular-weight
proteins
that
are
essential
for
modulating
lipoprotein
metabolism,
primarily
influencing
lipid
transport
and
metabolic
pathways.
Apoc1,
member
the
Apoc
family,
is
consistently
overexpressed
across
various
cancers,
significantly
correlating
with
poor
prognosis.
multifaceted
role
Apoc1
includes
promoting
cancer
progression
by
activating
key
signalling
pathways
such
as
epithelial-mesenchymal
transition
(EMT),
mitogen-activated
protein
kinases
(MAPK),
STAT3
WNT3
A.
Additionally,
contributes
to
regulatory
networks
involving
lncRNAs
miRNAs,
thereby
cancer.
This
comprehensive
review
delineates
Apoc1's
mechanisms
within
malignant
tumours
assesses
its
prognostic
implications
patients
aim
shed
light
on
potential
novel
therapeutic
strategies
in
oncology,
potentially
revolutionising
patient
care
enhancing
survival
rates
quality
life.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(23), P. 5565 - 5565
Published: Nov. 24, 2023
Apolipoproteins
(APOs)
are
vital
structural
components
of
plasma
lipoproteins
that
involved
in
lipid
metabolism
and
transport.
Recent
studies
have
reported
an
association
between
apolipoprotein
dysregulation
the
onset
a
variety
human
cancers;
however,
role
certain
APOs
cancer
development
remains
unknown.
Based
on
recent
work,
we
hypothesize
might
be
cancer,
with
focus
most
common
cancers,
including
breast,
lung,
gynecological,
colorectal,
thyroid,
gastric,
pancreatic,
hepatic,
prostate
cancers.
This
review
will
evidence
supporting
this
hypothesis,
mechanisms
linking
to
potential
clinical
relevance
its
various
inhibitors.